Unknown

Dataset Information

0

T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.


ABSTRACT: Purpose: This was a study prospectively evaluating intratumoral T-cell responses to autologous somatic mutated neoepitopes expressed by human metastatic ovarian cancers.Patients and Methods: Tumor-infiltrating lymphocytes (TIL) were expanded from resected ovarian cancer metastases, which were analyzed by whole-exome and transcriptome sequencing to identify autologous somatic mutations. All mutated neoepitopes, independent of prediction algorithms, were expressed in autologous antigen-presenting cells and then cocultured with TIL fragment cultures. Secretion of IFN? or upregulation of 41BB indicated a T-cell response.Results: Seven women with metastatic ovarian cancer were evaluated, and 5 patients had clear, dominant T-cell responses to mutated neoantigens, which were corroborated by comparison with the wild-type sequence, identification of the minimal epitope, human leukocyte antigen (HLA) restriction element(s), and neoantigen-specific T-cell receptor(s). Mutated neoantigens were restricted by HLA-B, -C, -DP, -DQ, and/or -DR alleles and appeared to principally arise from random, somatic mutations unique to each patient. We established that TP53 "hotspot" mutations (c.659A>G; p.Y220C and c.733G>A; p.G245S) expressed by two different patients' tumors were both immunogenic in the context of HLA-DRB3*02:02.Conclusions: Mutation-reactive T cells infiltrated ovarian cancer metastases at sufficient frequencies to warrant their investigation as adoptive cell therapy. In addition, transfer of TP53 "hotspot" mutation-reactive T-cell receptors into peripheral blood T cells could be evaluated as a gene therapy for a diverse range of tumor histologies. Clin Cancer Res; 24(22); 5562-73. ©2018 AACR See related commentary by McNeish, p. 5493.

SUBMITTER: Deniger DC 

PROVIDER: S-EPMC6239943 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.

Deniger Drew C DC   Pasetto Anna A   Robbins Paul F PF   Gartner Jared J JJ   Prickett Todd D TD   Paria Biman C BC   Malekzadeh Parisa P   Jia Li L   Yossef Rami R   Langhan Michelle M MM   Wunderlich John R JR   Danforth David N DN   Somerville Robert P T RPT   Rosenberg Steven A SA  

Clinical cancer research : an official journal of the American Association for Cancer Research 20180531 22


<b>Purpose:</b> This was a study prospectively evaluating intratumoral T-cell responses to autologous somatic mutated neoepitopes expressed by human metastatic ovarian cancers.<b>Patients and Methods:</b> Tumor-infiltrating lymphocytes (TIL) were expanded from resected ovarian cancer metastases, which were analyzed by whole-exome and transcriptome sequencing to identify autologous somatic mutations. All mutated neoepitopes, independent of prediction algorithms, were expressed in autologous antig  ...[more]

Similar Datasets

| S-EPMC7000721 | biostudies-literature
| S-EPMC5729536 | biostudies-literature
| S-EPMC7138461 | biostudies-literature
| S-EPMC2893110 | biostudies-literature
| S-EPMC5352183 | biostudies-literature
| S-EPMC4621916 | biostudies-literature
| S-EPMC6320227 | biostudies-literature
| S-EPMC5008065 | biostudies-literature
| S-EPMC5392013 | biostudies-literature
| S-EPMC7611203 | biostudies-literature